AskVantage

Mantis Biotechnology

Mantis Biotechnology is a startup headquartered in San Francisco, United States, founded in 2025. It has raised at least $4.8m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2025Founded
StartupStage
San Francisco, United StatesHeadquarters
BiotechnologyIndustry
$4.8m+Raised (SEC filings)
SeedFunding stage
Biotechnology
See it on the interactive mapBook a Briefing

Funding

Mantis Biotechnology has raised at least $4.8m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

Mantis Biotechnology sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.

Other startups in San Francisco

Related

Questions and answers

What does Mantis Biotechnology do?

Mantis Biotechnology is classed in biotechnology in its filings with the US Securities and Exchange Commission.

How much has Mantis Biotechnology raised?

At least $4.8m, according to its Form D filings with the US Securities and Exchange Commission.

Where is Mantis Biotechnology based?

Mantis Biotechnology is headquartered in San Francisco, United States.

When was Mantis Biotechnology founded?

Mantis Biotechnology was founded in 2025.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.